Search results
Results From The WOW.Com Content Network
Phage therapy has gained recent attention in the United States as an alternative to standard antibiotic therapy. [ 5 ] [ 6 ] [ 7 ] It has been in practice for just over 100 years in countries such as Russia and Georgia , but due to the recent clinical attention of antibiotic resistance , Western countries have slowly been integrating phage ...
Phage therapy, viral phage therapy, or phagotherapy is the therapeutic use of bacteriophages for the treatment of pathogenic bacterial infections. [1] [2] [3] This therapeutic approach emerged at the beginning of the 20th century but was progressively replaced by the use of antibiotics in most parts of the world after the Second World War.
Since her husband's release from hospital in 2016, Strathdee and her physician friend, Robert "Chip" Schooley, who was responsible for treating her husband, have been actively involved in helping other patients receive phage therapy [13] [14] and have launched the Center for Innovative Phage Applications and Therapeutics (IPATH), the first ...
The 'Nuts and Bolts' of Phage Therapy. a special issue of the journal, Current Pharmaceutical Biotechnology, consisting of six articles on phage therapy, plus an editorial. Carnazza, S., Guglielmino, S. eds. 2010. Phage Display As a Tool for Synthetic Biology. Nova Science Publishers, Hauppauge, New York. ISBN 978-1-60876-987-2, Google Books
Since bacteria become resistant against a single phage, d'Herelle suggested using "phage cocktails" containing different phage strains. Phage therapy soon became a boom, and a great hope in medicine. In 1924, 25 January, d'Hérelle received the honorary doctorate of the University of Leiden , [ 14 ] as well as the Leeuwenhoek medal , which is ...
Rakonjac specialises in the biology and structure of bacteriophages, and the development of technology for use in veterinary, medical, and agriculture fields. [2] [4] In 2003, she was awarded a Marsden grant to study bacteriophage technology, and in 2010 she was an associate investigator on a Fast Start Marsden grant led by Massey researcher Dragana Gagic, titled Stuck on you: exploring the ...
For premium support please call: 800-290-4726 more ways to reach us
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. [2] Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. [5]